| Literature DB >> 35343368 |
Brandy Perkins1, Margaret Showel1, Laura Schoch1, Philip H Imus1, Theodoros Karantanos1, Raluca Yonescu1, Laura Morsberger1, Gabriel Ghiaur1, Douglas E Gladstone1, Richard J Jones1.
Abstract
The clinical course of chronic lymphocytic leukemia (CLL) is highly variable. Immunoglobulin heavy chain variable region (IgHV) mutation status is among the most important prognostic factors, with unmutated IgHV associated with inferior outcomes. CLL presumably arises from mature B cells. However, we hypothesized that IgHV unmutated CLL could arise early in B cell differentiation. We prospectively studied 29 patients with mutated and 88 with unmutated IgHV CLL for the presence of CD34+CD19+ cells harboring CLL chromosomal abnormalities. CD34+CD19+ cells were never detected in mutated CLL. In contrast, a small but distinct population of CD34+CD19+ cells harboring the CLL chromosomal abnormality was present in 86/88 patients with unmutated IgHV across all cytogenetic subtypes. Moreover, the CD34+CD19+ cells generated a 3.8 ± 0.7 fold CLL cell expansion over 3-4 weeks in cultures containing IL-3 and IL-2. Unmutated IgHV CLL appears to arise in CD34+ B cells, which perhaps contributes to its poorer prognosis.Entities:
Keywords: CD19; CD34; Chronic lymphocytic leukemia (CLL); stem cells
Mesh:
Substances:
Year: 2022 PMID: 35343368 PMCID: PMC9276631 DOI: 10.1080/10428194.2022.2038375
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022